Theranos, the lab-testing company currently embroiled in questions about the legitimacy of its test methods, is reportedly preparing to shake up its board of directors.
According to a report from The New York Times, Theranos will announce that board members Henry Kissinger and George Schultz are among those who will exit.
Despite the changes — which come at a time when Theranos is operating under increased scrutiny from the FDA — the board reportedly says in a statment that it continues to support Theranos CEO, Elizabeth Holmes.
The statement, cited by The Times, says in part: “We stand wholeheartedly behind the management, achievements, vision and commitment of this company.”
More to come …
NOW WATCH: Briefing videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.